|
시장보고서
상품코드
1609693
일본의 올리고뉴클레오티드 합성 시장 보고서 : 제품, 용도, 최종 용도 및 지역별(2025-2033년)Japan Oligonucleotide Synthesis Market Report by Product, Application (PCR Primers, PCR Assays and Panels, Sequencing, DNA Microarrays, Fluorescence In-Situ Hybridization, Antisense Oligonucleotides, and Others), End Use, and Region 2025-2033 |
||||||
일본의 올리고뉴클레오티드 합성 시장 규모는 2024년 2억490만 달러로 추정됩니다. 향후 IMARC Group은 2033년까지 6억 3,000만 달러에 달할 것으로 예상하며, 2025-2033년 사이 11.42%의 연평균 성장률(CAGR)을 나타낼 것으로 예측했습니다. 바이오인포매틱스 및 데이터 사이언스의 괄목할만한 성장과 함께 새로운 치료 전략의 광범위한 채택이 시장 성장을 주도하고 있습니다.
본 보고서에서 다룬 주요 질문
- 일본의 올리고뉴클레오티드 합성 시장은 지금까지 어떻게 성장해왔고 앞으로 어떻게 발전할 것인가?
- 코로나19가 일본 올리고뉴클레오티드 합성 시장에 미치는 영향은?
- 일본 올리고뉴클레오티드 합성 시장의 제품별 구성비는?
- 일본 올리고뉴클레오티드 합성 시장의 용도별 시장 현황은?
- 일본 올리고뉴클레오티드 합성 시장 최종 용도별 분석은?
- 일본 올리고뉴클레오티드 합성 시장의 밸류체인에는 어떤 단계가 있는가?
- 일본의 올리고뉴클레오티드 합성의 주요 촉진요인과 과제는?
- 일본 올리고뉴클레오티드 합성 시장의 구조와 주요 업체는?
- 일본의 올리고뉴클레오티드 합성 시장에서의 경쟁은 어느 정도인가?
목차
제1장 서문
제2장 조사 범위와 조사 방법
- 조사 목적
- 이해관계자
- 데이터 소스
- 시장 추정
- 조사 방법
제3장 주요 요약
제4장 일본의 올리고뉴클레오티드 합성 시장 : 서론
- 개요
- 시장 역학
- 업계 동향
- 경쟁 정보
제5장 일본의 올리고뉴클레오티드 합성 시장 구도
- 과거 및 현재 시장 동향(2019-2024년)
- 시장 예측(2025-2033년)
제6장 일본의 올리고뉴클레오티드 합성 시장 : 제품별 분석
- 합성 올리고뉴클레오티드 제품
- 시약
- 장비
- 서비스
제7장 일본의 올리고뉴클레오티드 합성 시장 : 용도별 분석
- PCR 프라이머
- PCR 어세이 및 패널
- 시퀀싱
- DNA 마이크로어레이
- Fluorescence In-Situ Hybridization (FISH)
- 안티센스 올리고뉴클레오티드
- 기타
제8장 일본의 올리고뉴클레오티드 합성 시장 : 최종 용도별 분석
- 제약 기업 및 바이오테크놀러지 기업
- 병원 및 진단실험실
- 학술연구기관
제9장 일본의 올리고뉴클레오티드 합성 시장 : 경쟁 구도
- 개요
- 시장 구조
- 시장 기업 포지셔닝
- 주요 성공 전략
- 경쟁 대시보드
- 기업 평가 상한
제10장 주요 기업 개요
제11장 일본의 올리고뉴클레오티드 합성 시장 : 업계 분석
- 성장 촉진요인 및 억제요인과 기회
- Porter의 Five Forces 분석
- 밸류체인 분석
제12장 부록
LSH 24.12.23Japan oligonucleotide synthesis market size reached USD 204.9 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 603.0 Million by 2033, exhibiting a growth rate (CAGR) of 11.42% during 2025-2033. The widespread adoption of novel therapeutic strategies, coupled with significant growth of bioinformatics and data science, is primarily driving the market growth.
Oligonucleotide synthesis is the procedure for constructing short DNA or RNA molecules, known as oligonucleotides, with a specific sequence. These sequences can vary in length from just a few bases to approximately 200 nucleotides. This process is typically carried out through chemical synthesis in a controlled laboratory setting, often utilizing solid-phase phosphoramidite chemistry. In this approach, nucleotides are sequentially added to a growing chain, with each addition involving a series of chemical reactions. This technology allows scientists to create tailor-made oligonucleotides for a range of applications, including gene synthesis, polymerase chain reaction (PCR), gene editing tools like CRISPR-Cas9, and molecular diagnostic tests. Advances in oligonucleotide synthesis have greatly accelerated research in genomics and molecular biology, playing a pivotal role in numerous breakthroughs in medical and biological research.
Japan Oligonucleotide Synthesis Market Trends:
The Japanese market for oligonucleotides is primarily propelled by the increasing incidence of genetic diseases within the population. This necessitates the exploration of novel therapeutic approaches, with a significant role being played by oligonucleotide-based therapies. For example, therapies utilizing small interfering RNAs (siRNAs) and antisense oligonucleotides are being researched and applied in the treatment of genetic disorders like Duchenne muscular dystrophy and spinal muscular atrophy. Consequently, the growing prevalence of genetic diseases is driving demand not only in Japan but also on a wide scale. Furthermore, the expansion of bioinformatics and data science is directly impacting the oligonucleotide synthesis sector. The increasing capacity to analyze extensive genomic datasets is positively influencing the market by generating greater demand for the synthesis of innovative oligonucleotides. Additionally, oligonucleotides, particularly antisense oligonucleotides, have proven effective in epigenetic research and therapy, facilitating gene expression modulation and contributing to a favorable market outlook. Moreover, collaborations and partnerships between pharmaceutical companies, biotechnology firms, and research institutions have become crucial drivers in advancing the development and commercialization of oligonucleotide therapies for genetic diseases. These collaborative efforts are expected to fuel the regional market over the forecasted period.
Japan Oligonucleotide Synthesis Market Segmentation:
Product Insights:
- Synthesized Oligonucleotide Products
- Reagents
- Equipment
- Services
Application Insights:
- PCR Primers
- PCR Assays and Panels
- Sequencing
- DNA Microarrays
- Fluorescence In-Situ Hybridization (FISH)
- Antisense Oligonucleotides
- Others
End Use Insights:
- Pharmaceutical and Biotechnology Companies
- Hospital and Diagnostic Laboratories
- Academic Research Institutes
Competitive Landscape:
The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
Key Questions Answered in This Report:
- How has the Japan oligonucleotide synthesis market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the Japan oligonucleotide synthesis market?
- What is the breakup of the Japan oligonucleotide synthesis market on the basis of product?
- What is the breakup of the Japan oligonucleotide synthesis market on the basis of application?
- What is the breakup of the Japan oligonucleotide synthesis market on the basis of end use?
- What are the various stages in the value chain of the Japan oligonucleotide synthesis market?
- What are the key driving factors and challenges in the Japan oligonucleotide synthesis?
- What is the structure of the Japan oligonucleotide synthesis market and who are the key players?
- What is the degree of competition in the Japan oligonucleotide synthesis market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Japan Oligonucleotide Synthesis Market - Introduction
- 4.1 Overview
- 4.2 Market Dynamics
- 4.3 Industry Trends
- 4.4 Competitive Intelligence
5 Japan Oligonucleotide Synthesis Market Landscape
- 5.1 Historical and Current Market Trends (2019-2024)
- 5.2 Market Forecast (2025-2033)
6 Japan Oligonucleotide Synthesis Market - Breakup by Product
- 6.1 Synthesized Oligonucleotide Products
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2019-2024)
- 6.1.3 Market Forecast (2025-2033)
- 6.2 Reagents
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2019-2024)
- 6.2.3 Market Forecast (2025-2033)
- 6.3 Equipment
- 6.3.1 Overview
- 6.3.2 Historical and Current Market Trends (2019-2024)
- 6.3.3 Market Forecast (2025-2033)
- 6.4 Services
- 6.4.1 Overview
- 6.4.2 Historical and Current Market Trends (2019-2024)
- 6.4.3 Market Forecast (2025-2033)
7 Japan Oligonucleotide Synthesis Market - Breakup by Application
- 7.1 PCR Primers
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2019-2024)
- 7.1.3 Market Forecast (2025-2033)
- 7.2 PCR Assays and Panels
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2019-2024)
- 7.2.3 Market Forecast (2025-2033)
- 7.3 Sequencing
- 7.3.1 Overview
- 7.3.2 Historical and Current Market Trends (2019-2024)
- 7.3.3 Market Forecast (2025-2033)
- 7.4 DNA Microarrays
- 7.4.1 Overview
- 7.4.2 Historical and Current Market Trends (2019-2024)
- 7.4.3 Market Forecast (2025-2033)
- 7.5 Fluorescence In-Situ Hybridization (FISH)
- 7.5.1 Overview
- 7.5.2 Historical and Current Market Trends (2019-2024)
- 7.5.3 Market Forecast (2025-2033)
- 7.6 Antisense Oligonucleotides
- 7.6.1 Overview
- 7.6.2 Historical and Current Market Trends (2019-2024)
- 7.6.3 Market Forecast (2025-2033)
- 7.7 Others
- 7.7.1 Historical and Current Market Trends (2019-2024)
- 7.7.2 Market Forecast (2025-2033)
8 Japan Oligonucleotide Synthesis Market - Breakup by End Use
- 8.1 Pharmaceutical and Biotechnology Companies
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2019-2024)
- 8.1.3 Market Forecast (2025-2033)
- 8.2 Hospital and Diagnostic Laboratories
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2019-2024)
- 8.2.3 Market Forecast (2025-2033)
- 8.3 Academic Research Institutes
- 8.3.1 Overview
- 8.3.2 Historical and Current Market Trends (2019-2024)
- 8.3.3 Market Forecast (2025-2033)
9 Japan Oligonucleotide Synthesis Market - Competitive Landscape
- 9.1 Overview
- 9.2 Market Structure
- 9.3 Market Player Positioning
- 9.4 Top Winning Strategies
- 9.5 Competitive Dashboard
- 9.6 Company Evaluation Quadrant
10 Profiles of Key Players
- 10.1 Company A
- 10.1.1 Business Overview
- 10.1.2 Product Portfolio
- 10.1.3 Business Strategies
- 10.1.4 SWOT Analysis
- 10.1.5 Major News and Events
- 10.2 Company B
- 10.2.1 Business Overview
- 10.2.2 Product Portfolio
- 10.2.3 Business Strategies
- 10.2.4 SWOT Analysis
- 10.2.5 Major News and Events
- 10.3 Company C
- 10.3.1 Business Overview
- 10.3.2 Product Portfolio
- 10.3.3 Business Strategies
- 10.3.4 SWOT Analysis
- 10.3.5 Major News and Events
- 10.4 Company D
- 10.4.1 Business Overview
- 10.4.2 Product Portfolio
- 10.4.3 Business Strategies
- 10.4.4 SWOT Analysis
- 10.4.5 Major News and Events
- 10.5 Company E
- 10.5.1 Business Overview
- 10.5.2 Product Portfolio
- 10.5.3 Business Strategies
- 10.5.4 SWOT Analysis
- 10.5.5 Major News and Events
11 Japan Oligonucleotide Synthesis Market - Industry Analysis
- 11.1 Drivers, Restraints, and Opportunities
- 11.1.1 Overview
- 11.1.2 Drivers
- 11.1.3 Restraints
- 11.1.4 Opportunities
- 11.2 Porters Five Forces Analysis
- 11.2.1 Overview
- 11.2.2 Bargaining Power of Buyers
- 11.2.3 Bargaining Power of Suppliers
- 11.2.4 Degree of Competition
- 11.2.5 Threat of New Entrants
- 11.2.6 Threat of Substitutes
- 11.3 Value Chain Analysis
